CEBPA-DT (CEBPA divergent transcript)

2019-04-01  

Identity

HGNC
CEBPA-DT
LOCATION
19q13.11
LOCUSID
80054
ALIAS
ADINR,CEBPA-AS1

Other Information

Locus ID:

NCBI: 80054
HGNC: 25710
Ensembl: ENSG00000267296

Variants:

dbSNP: 80054
ClinVar: 80054
TCGA: ENSG00000267296
COSMIC: CEBPA-DT

RNA/Proteins

References

Pubmed IDYearTitleCitations
367158542023ZFX-mediated upregulation of CEBPA-AS1 contributes to acute myeloid leukemia progression through miR-24-3p/CTBP2 axis.1
367158542023ZFX-mediated upregulation of CEBPA-AS1 contributes to acute myeloid leukemia progression through miR-24-3p/CTBP2 axis.1
350882892022LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.1
350882892022LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.1
347900462021Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.4
347900462021Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.4
292815582018Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.26
292815582018Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.26

Citation

Dessen P

CEBPA-DT (CEBPA divergent transcript)

Atlas Genet Cytogenet Oncol Haematol. 2019-04-01

Online version: http://atlasgeneticsoncology.org/gene/57940/cebpa-dt-(cebpa-divergent-transcript)